Bipolar Depression: The 2026 PMHNP Treatment Algorithm
Bipolar depression demands a different algorithm than MDD. Here are the 2026 first-line options every PMHNP should have memorized — and the trap to avoid.
Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
Bipolar depression demands a different algorithm than MDD. Here are the 2026 first-line options every PMHNP should have memorized — and the trap to avoid.
More Articles
Countertransference is more than discomfort — for new PMHNPs, it's clinical data. A practical framework to spot it, name it, and use it safely.
A new PMHNP confidence script for declining inappropriate controlled substance requests — with exact language, rationale, and de-escalation frameworks.
A PMHNP earning $220K can save ~$9,500 a year by electing S-Corp. Here is the PLLC vs. S-Corp math, the 'reasonable salary' rule, and when to file Form 2553.
Lithium still works. The monitoring has changed. Here's the 2026 protocol PMHNPs need — baseline labs, dosing targets, and the GLP-1 era interactions.
PMHNP credentialing normally takes 90-150 days and delays up to $60K in revenue. Here's the 2026 playbook to launch faster.
New PMHNPs freeze when patients push back. Here is the 3-part script that holds the line, protects the alliance, and builds clinical confidence fast.
The PAX-D trial showed pramipexole reduced treatment-resistant depression symptoms by week 12. Here's what PMHNPs need to know about dosing, monitoring, and clinical use.
Four advanced certifications for PMHNPs that increase salary, sharpen clinical skills, and open doors to specialized roles in addiction, perinatal, pediatric, and rehab psychiatry.
Federal agencies reviewed 210 health plan analyses in 2026 and every single one failed MHPAEA compliance. Here is what that means for PMHNP reimbursement and patient access.